Investments
117Portfolio Exits
22Funds
1About Venture Investors
Venture Investors invests in healthcare and technology companies in the midwest United States. Venture Investors was founded in 1982 and focuses on making seed and early stage technology investments.
Venture Investors Headquarter Location
505 S. Rosa Rd. Suite 201
Madison, Wisconsin, 53719,
United States
608-441-2700
Expert Collections containing Venture Investors
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Venture Investors in 1 Expert Collection, including Pharma Startups.
Pharma Startups
5,090 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Research containing Venture Investors
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Venture Investors in 19 CB Insights research briefs, most recently on Oct 19, 2021.
Oct 19, 2021 report
Coinbase Strategy Teardown: How Coinbase Grew Into The King Midas Of Crypto
Sep 28, 2021
386 Startup Failure Post-Mortems
Jun 23, 2021 report
25 Business Moats That Helped Shape The World’s Most Massive Companies
Mar 17, 2021 report
How The Traditional Venture Capital Pipeline Is Changing
Latest Venture Investors News
Jul 25, 2021
Insider 6h agoVenture CapitalPrivate EquitybusinessinsiderViews: 26 Nontraditional investors deployed a record $57 billion into startups in the second quarter, research shows. Here's who is writing the most checks. - Access Over 250K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN
Venture Investors Investments
117 Investments
Venture Investors has made 117 investments. Their latest investment was in Health Scholars as part of their Series B - II on June 6, 2021.
Venture Investors Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/23/2021 | Series B - II | Health Scholars | $5.67M | No | 1 | |
3/11/2021 | Series C - II | SkySpecs | $10.16M | No | 1 | |
2/16/2021 | Series B | Iterion Therapeutics | $17M | Yes | 2 | |
6/8/2020 | Series C - II | |||||
5/19/2020 | Series A |
Date | 6/23/2021 | 3/11/2021 | 2/16/2021 | 6/8/2020 | 5/19/2020 |
|---|---|---|---|---|---|
Round | Series B - II | Series C - II | Series B | Series C - II | Series A |
Company | Health Scholars | SkySpecs | Iterion Therapeutics | ||
Amount | $5.67M | $10.16M | $17M | ||
New? | No | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 1 | 2 |
Venture Investors Portfolio Exits
22 Portfolio Exits
Venture Investors has 22 portfolio exits. Their latest portfolio exit was Euthymics Bioscience on November 01, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/1/2017 | Acquired | 1 | |||
10/3/2017 | Acquired | 2 | |||
3/16/2017 | Reverse Merger | 2 | |||
Date | 11/1/2017 | 10/3/2017 | 3/16/2017 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Reverse Merger | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 2 | 2 |
Venture Investors Fund History
1 Fund History
Venture Investors has 1 fund, including Venture Investors Health Fund 6.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
8/2/2019 | Venture Investors Health Fund 6 | $73.12M | 1 |
Closing Date | 8/2/2019 |
|---|---|
Fund | Venture Investors Health Fund 6 |
Fund Type | |
Status | |
Amount | $73.12M |
Sources | 1 |
Venture Investors Team
8 Team Members
Venture Investors has 8 team members, including current Managing Director, Jim Adox.
Name | Work History | Title | Status |
|---|---|---|---|
Jim Adox | Ridgeline Ventures, and EDF Ventures | Managing Director | Current |
Scott Button | Managing Director | Current | |
Roger Ganser | Managing Director | Current | |
John Neis | Managing Director | Current | |
Winslow Sargeant | Managing Director | Current |
Name | Jim Adox | Scott Button | Roger Ganser | John Neis | Winslow Sargeant |
|---|---|---|---|---|---|
Work History | Ridgeline Ventures, and EDF Ventures | ||||
Title | Managing Director | Managing Director | Managing Director | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |